| Quantitative analysis of immune infiltrates in primary melanoma RD Gartrell, DK Marks, TD Hart, G Li, DR Davari, A Wu, Z Blake, Y Lu, ... Cancer immunology research 6 (4), 481-493, 2018 | 104 | 2018 |
| Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men DK Marks, SE Goldstone JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (3), 259-265, 2012 | 90 | 2012 |
| The role of oncolytic viruses in the treatment of melanoma CAY Bayan, AT Lopez, RD Gartrell, KM Komatsubara, M Bogardus, ... Current oncology reports 20, 1-14, 2018 | 39 | 2018 |
| Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual … Z Blake, DK Marks, RD Gartrell, T Hart, P Horton, SK Cheng, B Taback, ... Journal for ImmunoTherapy of Cancer 6, 1-8, 2018 | 33 | 2018 |
| Diagnosis and management of neuropathies associated with plasma cell dyscrasias E Rosenbaum, D Marks, S Raza Hematological Oncology 36 (1), 3-14, 2018 | 24 | 2018 |
| The cancer cell dissemination machinery as an immunosuppressive niche: a new obstacle towards the era of cancer immunotherapy S Asiry, G Kim, PS Filippou, LR Sanchez, D Entenberg, DK Marks, ... Frontiers in immunology 12, 654877, 2021 | 23 | 2021 |
| Quantitative analysis of immune infiltrates in primary melanoma. Cancer Immunol. Res. 2018; 6: 481–493. doi: 10.1158/2326-6066 RD Gartrell, DK Marks, TD Hart, G Li, DR Davari, A Wu, Z Blake, Y Lu, ... CIR-17-0360.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 23 | |
| Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma RD Gartrell-Corrado, AX Chen, EM Rizk, DK Marks, MH Bogardus, ... Cancer research 80 (5), 1078-1087, 2020 | 21 | 2020 |
| Akt inhibition is associated with favorable immune profile changes within the tumor microenvironment of hormone receptor positive, HER2 negative breast cancer DK Marks, RD Gartrell, M El Asmar, S Boboila, T Hart, Y Lu, Q Pan, J Yu, ... Frontiers in oncology 10, 968, 2020 | 20 | 2020 |
| Validation of melanoma immune profile (MIP), a prognostic immune gene prediction score for stage II–III melanoma RD Gartrell, DK Marks, EM Rizk, M Bogardus, CL Gérard, LW Barker, Y Fu, ... Clinical Cancer Research 25 (8), 2494-2502, 2019 | 20 | 2019 |
| Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial K Kalinsky, JA Sparano, X Zhong, E Andreopoulou, B Taback, ... Clinical and Translational Oncology 20, 1474-1483, 2018 | 19 | 2018 |
| Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on … J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, ... The Journal of pathology 260 (5), 498-513, 2023 | 13 | 2023 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| First-in-human phase 1/2a study of a potent and novel CDK2-selective inhibitor PF-07104091 in patients (pts) with advanced solid tumors, enriched for CDK4/6 inhibitor resistant … TA Yap, AM Elhaddad, RN Grisham, JT Hamm, DK Marks, G Shapiro, ... Journal of Clinical Oncology 41 (16_suppl), 3010-3010, 2023 | 10 | 2023 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016 S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ... Journal for ImmunoTherapy of Cancer 4, 223-242, 2016 | 9 | 2016 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, ... The Journal of pathology 260 (5), 514-532, 2023 | 8 | 2023 |
| Tumor immune microenvironment and response to neoadjuvant chemotherapy in hormone receptor/HER2+ early stage breast cancer RS Vanguri, KM Fenn, MR Kearney, Q Wang, H Guo, DK Marks, C Chin, ... Clinical breast cancer 22 (6), 538-546, 2022 | 8 | 2022 |
| Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec C Audrey-Bayan, MH Trager, RD Gartrell-Corrado, EM Rizk, J Pradhan, ... Melanoma Research 30 (4), 410-415, 2020 | 7 | 2020 |
| Characterization and spatial localization of the tumor immune microenvironment in metastatic uveal melanoma. KM Komatsubara, RD Gartrell, CA Bayan, JS Pradhan, SS Hasan, ... Journal of Clinical Oncology 36 (15_suppl), 9570-9570, 2018 | 5 | 2018 |
| Anal cancer with mediastinal lymph node metastasis MA Shenoy, L Winnicka, L Mirsadraei, D Marks Gastrointestinal Tumors 8 (3), 134-137, 2021 | 4 | 2021 |
